{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:54:32Z","timestamp":1792871672746,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T00:00:00Z","timestamp":1225843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00403-008-0891-9","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T14:42:53Z","timestamp":1225896173000},"page":"71-81","source":"Crossref","is-referenced-by-count":79,"title":["CD4+CD25+ regulatory T cells in human lupus erythematosus"],"prefix":"10.1007","volume":"301","author":[{"given":"Annegret","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Beissert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,5]]},"reference":[{"key":"891_CR1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2006.06.005","volume":"27","author":"B Alvarado-Sanchez","year":"2006","unstructured":"Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D et al (2006) Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27:110\u2013118. doi: 10.1016\/j.jaut.2006.06.005","journal-title":"J Autoimmun"},{"key":"891_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clim.2007.12.010","volume":"127","author":"NA Azab","year":"2008","unstructured":"Azab NA, Bassyouni IH, Emad Y et al (2008) CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 127:151\u2013157. doi: 10.1016\/j.clim.2007.12.010","journal-title":"Clin Immunol"},{"key":"891_CR3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","volume":"167","author":"C Baecher-Allan","year":"2001","unstructured":"Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 167:1245\u20131253","journal-title":"J Immunol"},{"key":"891_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/0961203307080226","volume":"16","author":"S Barath","year":"2007","unstructured":"Barath S, Aleksza M, Tarr T et al (2007) Measurement of natural (CD4+CD25 high) and inducible (CD4+IL\u221210+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 16:489\u2013496. doi: 10.1177\/0961203307080226","journal-title":"Lupus"},{"key":"891_CR5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/08916930701610028","volume":"40","author":"S Barath","year":"2007","unstructured":"Barath S, Soltesz P, Kiss E et al (2007) The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity 40:521\u2013528. doi: 10.1080\/08916930701610028","journal-title":"Autoimmunity"},{"key":"891_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jid.5700004","volume":"126","author":"S Beissert","year":"2006","unstructured":"Beissert S, Schwarz A, Schwarz T (2006) Regulatory T cells. J Invest Dermatol 126:15\u201324. doi: 10.1038\/sj.jid.5700004","journal-title":"J Invest Dermatol"},{"key":"891_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20\u201321. doi: 10.1038\/83713","journal-title":"Nat Genet"},{"key":"891_CR8","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","volume":"105","author":"CL Berger","year":"2005","unstructured":"Berger CL, Tigelaar R, Cohen J et al (2005) Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105:1640\u20131647. doi: 10.1182\/blood-2004-06-2181","journal-title":"Blood"},{"key":"891_CR9","first-page":"S67","volume":"24","author":"M Bohm","year":"2006","unstructured":"Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A (2006) New insight into immunosuppression and treatment of autoimmune diseases. Clin Exp Rheumatol 24:S67\u2013S71","journal-title":"Clin Exp Rheumatol"},{"key":"891_CR10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","volume":"20","author":"M Bonelli","year":"2008","unstructured":"Bonelli M, Savitskaya A, von Dalwigk K et al (2008) Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 20:861\u2013868. doi: 10.1093\/intimm\/dxn044","journal-title":"Int Immunol"},{"key":"891_CR11","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2003-07-2598","volume":"103","author":"O Boyer","year":"2004","unstructured":"Boyer O, Saadoun D, Abriol J et al (2004) CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103:3428\u20133430. doi: 10.1182\/blood-2003-07-2598","journal-title":"Blood"},{"key":"891_CR12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","volume":"27","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Jeffery EW, Hjerrild KA et al (2001) Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27:68\u201373. doi: 10.1038\/83784","journal-title":"Nat Genet"},{"key":"891_CR13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-3083.2006.001755.x","volume":"63","author":"D Cao","year":"2006","unstructured":"Cao D, Borjesson O, Larsson P et al (2006) FOXP3 identifies regulatory CD25bright CD4+T cells in rheumatic joints. Scand J Immunol 63:444\u2013452. doi: 10.1111\/j.1365-3083.2006.001755.x","journal-title":"Scand J Immunol"},{"key":"891_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/immu.200390024","volume":"33","author":"D Cao","year":"2003","unstructured":"Cao D, Malmstrom V, Baecher-Allan C et al (2003) Isolation and functional characterization of regulatory CD25brightCD4+T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215\u2013223. doi: 10.1002\/immu.200390024","journal-title":"Eur J Immunol"},{"key":"891_CR15","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","volume":"6","author":"D Cao","year":"2004","unstructured":"Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmstrom V (2004) CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 6:R335\u2013R346. doi: 10.1186\/ar1192","journal-title":"Arthritis Res Ther"},{"key":"891_CR16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0961203307077990","volume":"16","author":"AM Cepika","year":"2007","unstructured":"Cepika AM, Marinic I, Morovic-Vergles J, Soldo-Juresa D, Gagro A (2007) Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 16:374\u2013377. doi: 10.1177\/0961203307077990","journal-title":"Lupus"},{"key":"891_CR17","doi-asserted-by":"crossref","unstructured":"Chatila TA (2005) Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116:949\u2013959. quiz 960. doi: 10.1016\/j.jaci.2005.08.047","DOI":"10.1016\/j.jaci.2005.08.047"},{"key":"891_CR18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coi.2006.07.007","volume":"18","author":"JL Cohen","year":"2006","unstructured":"Cohen JL, Boyer O (2006) The role of CD4+CD25 high regulatory T cells in the physiopathogeny of graft-versus-host disease. Curr Opin Immunol 18:580\u2013585. doi: 10.1016\/j.coi.2006.07.007","journal-title":"Curr Opin Immunol"},{"key":"891_CR19","doi-asserted-by":"crossref","first-page":"89195","DOI":"10.1155\/2007\/89195","volume":"2007","author":"N Cools","year":"2007","unstructured":"Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN (2007) Regulatory T cells and human disease. Clin Dev Immunol 2007:89195. doi: 10.1155\/2007\/89195","journal-title":"Clin Dev Immunol"},{"key":"891_CR20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/eji.200738104","volume":"38","author":"CM Costantino","year":"2008","unstructured":"Costantino CM, Baecher-Allan CM, Hafler DA (2008) Human regulatory T cells and autoimmunity. Eur J Immunol 38:921\u2013924. doi: 10.1002\/eji.200738104","journal-title":"Eur J Immunol"},{"key":"891_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0896-8411(03)00121-5","volume":"21","author":"JC Crispin","year":"2003","unstructured":"Crispin JC, Martinez A, Alcocer-Varela J (2003) Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21:273\u2013276. doi: 10.1016\/S0896-8411(03)00121-5","journal-title":"J Autoimmun"},{"key":"891_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","volume":"117","author":"C Dejaco","year":"2006","unstructured":"Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M (2006) Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117:289\u2013300. doi: 10.1111\/j.1365-2567.2005.02317.x","journal-title":"Immunology"},{"key":"891_CR23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","volume":"193","author":"D Dieckmann","year":"2001","unstructured":"Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193:1303\u20131310. doi: 10.1084\/jem.193.11.1303","journal-title":"J Exp Med"},{"key":"891_CR24","first-page":"25","volume":"12","author":"A Fathy","year":"2005","unstructured":"Fathy A, Mohamed RW, Tawfik GA, Omar AS (2005) Diminished CD4+CD25+ T-lymphocytes in peripheral blood of patients with systemic lupus erythematosus. Egypt J Immunol 12:25\u201331","journal-title":"Egypt J Immunol"},{"key":"891_CR25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330\u2013336. doi: 10.1038\/ni904","journal-title":"Nat Immunol"},{"key":"891_CR26","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.22699","volume":"56","author":"B Franz","year":"2007","unstructured":"Franz B, Fritzsching B, Riehl A et al (2007) Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 56:1910\u20131920. doi: 10.1002\/art.22699","journal-title":"Arthritis Rheum"},{"key":"891_CR27","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","volume":"174","author":"DC Gondek","year":"2005","unstructured":"Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ (2005) Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174:1783\u20131786","journal-title":"J Immunol"},{"key":"891_CR28","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","volume":"35","author":"J Haas","year":"2005","unstructured":"Haas J, Hug A, Viehover A et al (2005) Reduced suppressive effect of CD4+CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35:3343\u20133352. doi: 10.1002\/eji.200526065","journal-title":"Eur J Immunol"},{"key":"891_CR29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061. doi: 10.1126\/science.1079490","journal-title":"Science"},{"key":"891_CR30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","volume":"193","author":"H Jonuleit","year":"2001","unstructured":"Jonuleit H, Schmitt E, Stassen M et al (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285\u20131294. doi: 10.1084\/jem.193.11.1285","journal-title":"J Exp Med"},{"key":"891_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337\u2013342. doi: 10.1038\/ni909","journal-title":"Nat Immunol"},{"key":"891_CR32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.leu.2404182","volume":"20","author":"CD Klemke","year":"2006","unstructured":"Klemke CD, Fritzsching B, Franz B et al (2006) Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas. Leukemia 20:1123\u20131129. doi: 10.1038\/sj.leu.2404182","journal-title":"Leukemia"},{"key":"891_CR33","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.20032158","volume":"199","author":"MA Kriegel","year":"2004","unstructured":"Kriegel MA, Lohmann T, Gabler C et al (2004) Defective suppressor function of human CD4+CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199:1285\u20131291. doi: 10.1084\/jem.20032158","journal-title":"J Exp Med"},{"key":"891_CR34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0961203308090019","volume":"17","author":"A Kuhn","year":"2008","unstructured":"Kuhn A, Bijl M (2008) Pathogenesis of cutaneous lupus erythematosus. Lupus 17:389\u2013393. doi: 10.1177\/0961203308090019","journal-title":"Lupus"},{"key":"891_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","volume":"109","author":"A Kukreja","year":"2002","unstructured":"Kukreja A, Cost G, Marker J et al (2002) Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131\u2013140","journal-title":"J Clin Invest"},{"key":"891_CR36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/ken108","volume":"47","author":"HY Lee","year":"2008","unstructured":"Lee HY, Hong YK, Yun HJ et al (2008) Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatol (Oxf) 47:789\u2013794. doi: 10.1093\/rheumatology\/ken108","journal-title":"Rheumatol (Oxf)"},{"key":"891_CR37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2005.02306.x","volume":"117","author":"JH Lee","year":"2006","unstructured":"Lee JH, Wang LC, Lin YT et al (2006) Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117:280\u2013286. doi: 10.1111\/j.1365-2567.2005.02306.x","journal-title":"Immunology"},{"key":"891_CR38","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","volume":"175","author":"HW Lim","year":"2005","unstructured":"Lim HW, Hillsamer P, Banham AH, Kim CH (2005) Cutting edge: direct suppression of B cells by CD4+CD25+ regulatory T cells. J Immunol 175:4180\u20134183","journal-title":"J Immunol"},{"key":"891_CR39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2362.2007.01882.x","volume":"37","author":"SC Lin","year":"2007","unstructured":"Lin SC, Chen KH, Lin CH et al (2007) The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37:987\u2013996. doi: 10.1111\/j.1365-2362.2007.01882.x","journal-title":"Eur J Clin Invest"},{"key":"891_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","volume":"54","author":"S Lindley","year":"2005","unstructured":"Lindley S, Dayan CM, Bishop A et al (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54:92\u201399. doi: 10.2337\/diabetes.54.1.92","journal-title":"Diabetes"},{"key":"891_CR41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.yadr.2007.07.014","volume":"23","author":"K Loser","year":"2007","unstructured":"Loser K, Beissert S (2007) Dendritic cells and T cells in the regulation of cutaneous immunity. Adv Dermatol 23:307\u2013333. doi: 10.1016\/j.yadr.2007.07.014","journal-title":"Adv Dermatol"},{"key":"891_CR42","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.174.9.5298","volume":"174","author":"K Loser","year":"2005","unstructured":"Loser K, Scherer A, Krummen MB et al (2005) An important role of CD80\/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J Immunol 174:5298\u20135305","journal-title":"J Immunol"},{"key":"891_CR43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-0-387-72005-0_12","volume":"601","author":"EY Lyssuk","year":"2007","unstructured":"Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN (2007) Reduced number and function of CD4+CD25 highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 601:113\u2013119","journal-title":"Adv Exp Med Biol"},{"key":"891_CR44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/ard.2005.044974","volume":"65","author":"S Mellor-Pita","year":"2006","unstructured":"Mellor-Pita S, Citores MJ, Castejon R et al (2006) Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis 65:553\u2013554. doi: 10.1136\/ard.2005.044974","journal-title":"Ann Rheum Dis"},{"key":"891_CR45","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","volume":"175","author":"M Miyara","year":"2005","unstructured":"Miyara M, Amoura Z, Parizot C et al (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175:8392\u20138400","journal-title":"J Immunol"},{"key":"891_CR46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","volume":"203","author":"M Miyara","year":"2006","unstructured":"Miyara M, Amoura Z, Parizot C et al (2006) The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203:359\u2013370. doi: 10.1084\/jem.20050648","journal-title":"J Exp Med"},{"key":"891_CR47","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/art.20976","volume":"52","author":"CR Monk","year":"2005","unstructured":"Monk CR, Spachidou M, Rovis F et al (2005) MRL\/Mp CD4+, CD25-T cells show reduced sensitivity to suppression by CD4+, CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 52:1180\u20131184. doi: 10.1002\/art.20976","journal-title":"Arthritis Rheum"},{"key":"891_CR48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaci.2004.01.772","volume":"113","author":"LS Ou","year":"2004","unstructured":"Ou LS, Goleva E, Hall C, Leung DY (2004) T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 113:756\u2013763. doi: 10.1016\/j.jaci.2004.01.772","journal-title":"J Allergy Clin Immunol"},{"key":"891_CR49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4049\/jimmunol.167.3.1137","volume":"167","author":"CA Piccirillo","year":"2001","unstructured":"Piccirillo CA, Shevach EM (2001) Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 167:1137\u20131140","journal-title":"J Immunol"},{"key":"891_CR50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ni0103-10","volume":"4","author":"S Sakaguchi","year":"2003","unstructured":"Sakaguchi S (2003) Regulatory T cells: mediating compromises between host and parasite. Nat Immunol 4:10\u201311. doi: 10.1038\/ni0103-10","journal-title":"Nat Immunol"},{"key":"891_CR51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531\u2013562. doi: 10.1146\/annurev.immunol.21.120601.141122","journal-title":"Annu Rev Immunol"},{"key":"891_CR52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/eji.200890012","volume":"38","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S (2008) Regulatory T cells in the past and for the future. Eur J Immunol 38:901\u2013937. doi: 10.1002\/eji.200890012","journal-title":"Eur J Immunol"},{"key":"891_CR53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/08830180590934976","volume":"24","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S, Sakaguchi N (2005) Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 24:211\u2013226. doi: 10.1080\/08830180590934976","journal-title":"Int Rev Immunol"},{"key":"891_CR54","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151\u20131164","journal-title":"J Immunol"},{"key":"891_CR55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","volume":"182","author":"S Sakaguchi","year":"2001","unstructured":"Sakaguchi S, Sakaguchi N, Shimizu J et al (2001) Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18\u201332. doi: 10.1034\/j.1600-065X.2001.1820102.x","journal-title":"Immunol Rev"},{"key":"891_CR56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","volume":"123","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Souliotis VL, Fragiadaki KG et al (2007) Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 123:66\u201373. doi: 10.1016\/j.clim.2006.12.006","journal-title":"Clin Immunol"},{"key":"891_CR57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","volume":"18","author":"EM Shevach","year":"2000","unstructured":"Shevach EM (2000) Regulatory T cells in autoimmmunity. Annu Rev Immunol 18:423\u2013449. doi: 10.1146\/annurev.immunol.18.1.423","journal-title":"Annu Rev Immunol"},{"key":"891_CR58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","volume":"2","author":"EM Shevach","year":"2002","unstructured":"Shevach EM (2002) CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2:389\u2013400","journal-title":"Nat Rev Immunol"},{"key":"891_CR59","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.176.3.1582","volume":"176","author":"MJ Smyth","year":"2006","unstructured":"Smyth MJ, Teng MW, Swann J et al (2006) CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 176:1582\u20131587","journal-title":"J Immunol"},{"key":"891_CR60","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/ard.2005.049924","volume":"65","author":"A Suarez","year":"2006","unstructured":"Suarez A, Lopez P, Gomez J, Gutierrez C (2006) Enrichment of CD4+CD25 high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 65:1512\u20131517. doi: 10.1136\/ard.2005.049924","journal-title":"Ann Rheum Dis"},{"key":"891_CR61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","volume":"174","author":"H Sugiyama","year":"2005","unstructured":"Sugiyama H, Gyulai R, Toichi E et al (2005) Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174:164\u2013173","journal-title":"J Immunol"},{"key":"891_CR62","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","volume":"172","author":"AM Thornton","year":"2004","unstructured":"Thornton AM, Donovan EE, Piccirillo CA, Shevach EM (2004) Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172:6519\u20136523","journal-title":"J Immunol"},{"key":"891_CR63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287\u2013296. doi: 10.1084\/jem.188.2.287","journal-title":"J Exp Med"},{"key":"891_CR64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","volume":"164","author":"AM Thornton","year":"2000","unstructured":"Thornton AM, Shevach EM (2000) Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164:183\u2013190","journal-title":"J Immunol"},{"key":"891_CR65","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2004.04.003","volume":"112","author":"P Trzonkowski","year":"2004","unstructured":"Trzonkowski P, Szmit E, Mysliwska J, Dobyszuk A, Mysliwski A (2004) CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 112:258\u2013267. doi: 10.1016\/j.clim.2004.04.003","journal-title":"Clin Immunol"},{"key":"891_CR66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","volume":"108","author":"X Valencia","year":"2006","unstructured":"Valencia X, Stephens G, Goldbach-Mansky R et al (2006) TNF downmodulates the function of human CD4+CD25high T-regulatory cells. Blood 108:253\u2013261. doi: 10.1182\/blood-2005-11-4567","journal-title":"Blood"},{"key":"891_CR67","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","volume":"178","author":"X Valencia","year":"2007","unstructured":"Valencia X, Yarboro C, Illei G, Lipsky PE (2007) Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178:2579\u20132588","journal-title":"J Immunol"},{"key":"891_CR68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clim.2006.08.016","volume":"122","author":"T Vallerskog","year":"2007","unstructured":"Vallerskog T, Gunnarsson I, Widhe M et al (2007) Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122:62\u201374. doi: 10.1016\/j.clim.2006.08.016","journal-title":"Clin Immunol"},{"key":"891_CR69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0961203307088307","volume":"17","author":"MI Vargas-Rojas","year":"2008","unstructured":"Vargas-Rojas MI, Crispin JC, Richaud-Patin Y, Alcocer-Varela J (2008) Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17:289\u2013294. doi: 10.1177\/0961203307088307","journal-title":"Lupus"},{"key":"891_CR70","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971\u2013979. doi: 10.1084\/jem.20031579","journal-title":"J Exp Med"},{"key":"891_CR71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(03)00359-5","volume":"20","author":"HY Wang","year":"2004","unstructured":"Wang HY, Lee DA, Peng G et al (2004) Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20:107\u2013118. doi: 10.1016\/S1074-7613(03)00359-5","journal-title":"Immunity"},{"key":"891_CR72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin RS, Ramsdell F, Peake J et al (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18\u201320. doi: 10.1038\/83707","journal-title":"Nat Genet"},{"key":"891_CR73","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2567.2002.01412.x","volume":"106","author":"K Wing","year":"2002","unstructured":"Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E (2002) Characterization of human CD25+CD4+ T cells in thymus, cord and adult blood. Immunology 106:190\u2013199. doi: 10.1046\/j.1365-2567.2002.01412.x","journal-title":"Immunology"},{"key":"891_CR74","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1191\/0961203303lu1002oa","volume":"13","author":"HY Wu","year":"2004","unstructured":"Wu HY, Staines NA (2004) A deficiency of CD4+CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus 13:192\u2013200. doi: 10.1191\/0961203303lu1002oa","journal-title":"Lupus"},{"key":"891_CR75","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/art.23268","volume":"58","author":"B Yan","year":"2008","unstructured":"Yan B, Ye S, Chen G et al (2008) Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 58:801\u2013812. doi: 10.1002\/art.23268","journal-title":"Arthritis Rheum"},{"key":"891_CR76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2249.2008.03686.x","volume":"153","author":"B Zhang","year":"2008","unstructured":"Zhang B, Zhang X, Tang F, Zhu L, Liu Y (2008) Reduction of forkhead box P3 levels in CD4(+)CD25(high) T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol 153:182\u2013187","journal-title":"Clin Exp Immunol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0891-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-008-0891-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0891-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:53:29Z","timestamp":1684619609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-008-0891-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,5]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1007\/s00403-008-0891-9","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,5]]}}}